Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
BMS CA184-043 : Essai de phase 3 randomisé, en double aveugle, comparant l’efficacité de l'ipilimumab, en traitement post-radiothérapie, chez des patients ayant un cancer de la prostate hormono-résistant. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions] https://www.kusajili.com:443/Trial/NjcMiMbSSkSYi_r7C-ZWNA%24bms-ca184-043-essai-de-phase-3-randomise-en-double-aveugle-comparant-lefficacite-de-lipilimumab-en-traitement-post-radiotherapi
I have read and accept the terms of use of the site and the Privacy Policy
Send your message